Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Express Scripts
Cantor Fitzgerald
AstraZeneca
Merck
Deloitte
Covington
Fish and Richardson

Generated: November 12, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 064032

« Back to Dashboard

NDA 064032 describes TAZICEF, which is a drug marketed by Hospira and is included in two NDAs. It is available from one supplier. Additional details are available on the TAZICEF profile page.

The generic ingredient in TAZICEF is ceftazidime. There are seventeen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.
Summary for 064032
Tradename:TAZICEF
Applicant:Hospira
Ingredient:ceftazidime
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 064032
Ingredient-typeCephalosporins
Medical Subject Heading (MeSH) Categories for 064032
Suppliers and Packaging for NDA: 064032
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TAZICEF ceftazidime INJECTABLE;INJECTION 064032 ANDA Hospira, Inc. 0409-5092 0409-5092-16 25 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-5092-16) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM
TAZICEF ceftazidime INJECTABLE;INJECTION 064032 ANDA Hospira, Inc. 0409-5093 0409-5093-11 10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-5093-11) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1GM/VIAL
Approval Date:Oct 31, 1993TE:APRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2GM/VIAL
Approval Date:Oct 31, 1993TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Teva
Mallinckrodt
Covington
Chubb
QuintilesIMS
US Department of Justice
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.